Vigilare Wealth Management lowered its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 17.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,709 shares of the healthcare conglomerate’s stock after selling 367 shares during the quarter. UnitedHealth Group accounts for approximately 0.5% of Vigilare Wealth Management’s holdings, making the stock its 29th biggest holding. Vigilare Wealth Management’s holdings in UnitedHealth Group were worth $821,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Chelsea Counsel Co. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $27,000. 25 LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth about $28,000. Freedom Wealth Alliance LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $31,000. Cascade Investment Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter worth about $28,000. Finally, Kalos Management Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter worth about $34,000. Institutional investors and hedge funds own 85.69% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on UNH shares. Stephens reaffirmed an “overweight” rating and set a $560.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 11th. UBS Group boosted their price objective on shares of UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a research report on Wednesday, July 19th. Truist Financial decreased their target price on shares of UnitedHealth Group from $610.00 to $580.00 in a research report on Wednesday, June 14th. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $592.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, July 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Thursday, September 14th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $575.65.
UnitedHealth Group Stock Down 0.1 %
UNH stock opened at $486.06 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $558.10. The firm has a market cap of $450.24 billion, a PE ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. The firm has a 50 day simple moving average of $492.05 and a 200 day simple moving average of $486.73. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, beating the consensus estimate of $5.92 by $0.22. The business had revenue of $92.90 billion during the quarter, compared to analyst estimates of $90.97 billion. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The business’s quarterly revenue was up 15.6% on a year-over-year basis. During the same period in the prior year, the business earned $5.57 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 24.83 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be given a $1.88 dividend. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.65%.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total value of $2,024,760.00. Following the transaction, the chief executive officer now owns 78,573 shares in the company, valued at approximately $39,772,866.87. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.35% of the stock is owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- 10 Best Airline Stocks to Buy
- 5 Reasons Mullen Automotive is About to Turn a Corner
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.